$2.280
-0.123 (-5.39%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CTMX Prediction & Forecast by Similar Chart Analysis
Alphio's CTMX stock price prediction model matches the current CytomX Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.26 (-0.94%). The 1-week path is $2.28 (-0.03%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy CytomX Therapeutics Inc Stock?
CytomX Therapeutics Inc is not a good buy right now. The current price is $2.28, which is significantly below the average analyst price target of $11 to $14, indicating potential upside. However, the stock has seen a staggering 46.35% year-to-date decline and a 92.4% year-over-year revenue drop to $1.42 million, which raises serious concerns about its financial health. The RSI is at 33.876, indicating oversold conditions, but the overall negative sentiment from recent earnings misses and cash reserve declines suggests caution. The main risk is the company's substantial revenue decline and ongoing losses, as evidenced by a net income of -$20.67 million in Q2 2026, which could further impact investor confidence and stock performance.
CTMX stock price ended at $2.28 on Friday, after losing -5.39%
CytomX Therapeutics Inc (CTMX) last closed at $2.28, losing -5.39%. These facts feed the 1-day and 1-week CTMX price prediction above.
Analyst Consensus
CytomX Therapeutics Inc (CTMX): 6 buy, 1 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
CytomX Therapeutics Inc (CTMX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CTMX, ranked by similarity.
Seasonality analysis for CTMX
Historically the probability of a positive October return for CTMX is 39.66%. March offers the highest probability of a positive month at 63.49%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CTMX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $2.92 | $2.97 | $3.01 | +30.41% |
| Nov 2026 | $1.41 | $2.39 | $2.99 | +4.76% |
| Dec 2026 | $2.59 | $3.13 | $4.13 | +37.44% |
In 2026, CytomX Therapeutics Inc (CTMX) is projected to range from $1.41 to $4.13.
CytomX Therapeutics Inc 2026 monthly forecast
In Oct 2026, CytomX Therapeutics Inc is projected to average $2.97, with a low of $2.92 and high of $3.01.
In Nov 2026, CytomX Therapeutics Inc is projected to average $2.39, with a low of $1.41 and high of $2.99.
In Dec 2026, CytomX Therapeutics Inc is projected to average $3.13, with a low of $2.59 and high of $4.13.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.